1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immune Globulin Intravenous Revenue
1.4 Market Analysis by Type
1.4.1 Global Immune Globulin Intravenous Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 IVIg Liquid
1.4.3 IVIg Powder
1.5 Market by Application
1.5.1 Global Immune Globulin Intravenous Market Share by Application: 2021-2026
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Immune Globulin Intravenous Market
1.8.1 Global Immune Globulin Intravenous Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Immune Globulin Intravenous Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Immune Globulin Intravenous Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Immune Globulin Intravenous Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Immune Globulin Intravenous Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Immune Globulin Intravenous Sales Volume Market Share by Region (2015-2020)
3.2 Global Immune Globulin Intravenous Sales Revenue Market Share by Region (2015-2020)
3.3 North America Immune Globulin Intravenous Sales Volume
3.3.1 North America Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.3.2 North America Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Immune Globulin Intravenous Sales Volume
3.4.1 East Asia Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Immune Globulin Intravenous Sales Volume (2015-2020)
3.5.1 Europe Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Immune Globulin Intravenous Sales Volume (2015-2020)
3.6.1 South Asia Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Immune Globulin Intravenous Sales Volume (2015-2020)
3.7.1 Southeast Asia Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Immune Globulin Intravenous Sales Volume (2015-2020)
3.8.1 Middle East Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Immune Globulin Intravenous Sales Volume (2015-2020)
3.9.1 Africa Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Immune Globulin Intravenous Sales Volume (2015-2020)
3.10.1 Oceania Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Immune Globulin Intravenous Sales Volume (2015-2020)
3.11.1 South America Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.11.2 South America Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Immune Globulin Intravenous Sales Volume (2015-2020)
3.12.1 Rest of the World Immune Globulin Intravenous Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Immune Globulin Intravenous Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Immune Globulin Intravenous Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Immune Globulin Intravenous Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Immune Globulin Intravenous Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Immune Globulin Intravenous Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Immune Globulin Intravenous Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Immune Globulin Intravenous Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Immune Globulin Intravenous Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Immune Globulin Intravenous Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Immune Globulin Intravenous Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Immune Globulin Intravenous Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Immune Globulin Intravenous Sales Volume Market Share by Type (2015-2020)
14.2 Global Immune Globulin Intravenous Sales Revenue Market Share by Type (2015-2020)
14.3 Global Immune Globulin Intravenous Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Immune Globulin Intravenous Consumption Volume by Application (2015-2020)
15.2 Global Immune Globulin Intravenous Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Immune Globulin Intravenous Business
16.1 Baxter
16.1.1 Baxter Company Profile
16.1.2 Baxter Immune Globulin Intravenous Product Specification
16.1.3 Baxter Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 CNBG
16.2.1 CNBG Company Profile
16.2.2 CNBG Immune Globulin Intravenous Product Specification
16.2.3 CNBG Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Octapharma
16.3.1 Octapharma Company Profile
16.3.2 Octapharma Immune Globulin Intravenous Product Specification
16.3.3 Octapharma Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Grifols
16.4.1 Grifols Company Profile
16.4.2 Grifols Immune Globulin Intravenous Product Specification
16.4.3 Grifols Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Hualan Bio
16.5.1 Hualan Bio Company Profile
16.5.2 Hualan Bio Immune Globulin Intravenous Product Specification
16.5.3 Hualan Bio Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 CSL
16.6.1 CSL Company Profile
16.6.2 CSL Immune Globulin Intravenous Product Specification
16.6.3 CSL Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 CBPO
16.7.1 CBPO Company Profile
16.7.2 CBPO Immune Globulin Intravenous Product Specification
16.7.3 CBPO Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Kedrion
16.8.1 Kedrion Company Profile
16.8.2 Kedrion Immune Globulin Intravenous Product Specification
16.8.3 Kedrion Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Biotest
16.9.1 Biotest Company Profile
16.9.2 Biotest Immune Globulin Intravenous Product Specification
16.9.3 Biotest Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Shanghai RAAS
16.10.1 Shanghai RAAS Company Profile
16.10.2 Shanghai RAAS Immune Globulin Intravenous Product Specification
16.10.3 Shanghai RAAS Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 LFB Group
16.11.1 LFB Group Company Profile
16.11.2 LFB Group Immune Globulin Intravenous Product Specification
16.11.3 LFB Group Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 BPL
16.12.1 BPL Company Profile
16.12.2 BPL Immune Globulin Intravenous Product Specification
16.12.3 BPL Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Sichuan Yuanda Shuyang
16.13.1 Sichuan Yuanda Shuyang Company Profile
16.13.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Specification
16.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Immune Globulin Intravenous Manufacturing Cost Analysis
17.1 Immune Globulin Intravenous Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Immune Globulin Intravenous
17.4 Immune Globulin Intravenous Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Immune Globulin Intravenous Distributors List
18.3 Immune Globulin Intravenous Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Immune Globulin Intravenous (2021-2026)
20.2 Global Forecasted Revenue of Immune Globulin Intravenous (2021-2026)
20.3 Global Forecasted Price of Immune Globulin Intravenous (2015-2026)
20.4 Global Forecasted Production of Immune Globulin Intravenous by Region (2021-2026)
20.4.1 North America Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.3 Europe Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.7 Africa Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.9 South America Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Immune Globulin Intravenous Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Immune Globulin Intravenous by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Immune Globulin Intravenous by Country
21.2 East Asia Market Forecasted Consumption of Immune Globulin Intravenous by Country
21.3 Europe Market Forecasted Consumption of Immune Globulin Intravenous by Countriy
21.4 South Asia Forecasted Consumption of Immune Globulin Intravenous by Country
21.5 Southeast Asia Forecasted Consumption of Immune Globulin Intravenous by Country
21.6 Middle East Forecasted Consumption of Immune Globulin Intravenous by Country
21.7 Africa Forecasted Consumption of Immune Globulin Intravenous by Country
21.8 Oceania Forecasted Consumption of Immune Globulin Intravenous by Country
21.9 South America Forecasted Consumption of Immune Globulin Intravenous by Country
21.10 Rest of the world Forecasted Consumption of Immune Globulin Intravenous by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer